The current goals of the HU CFAR are the product of over twenty five years of commitment of HU and its affiliated institutions and their investigators to AIDS research, education, and patient care and builds on the existing and interactive CFAR infrastructure that has continued to grow since expansion into Harvard-wide CFAR in 2007. The scientific foundation of the proposed CFAR is the history of significant contributions to AIDS research made by investigators in the Harvard community. Harvard and its affiliated institutions have conducted an extraordinary breadth and depth of investigations in AIDS and related fields of research. Activities among the 144 NIH-funded HU investigators doing AIDS related research activities include studies of molecular virology, pathogenesis, host immune responses, epidemiology, treatment, vaccines and prevention, to which Harvard investigators have made consistent, high-impact contributions.
The HU CFAR encompasses clinical and basic science research conducted at HU and its affiliated institutions: